Walvax Biotechnology Co Ltd - ESG Rating & Company Profile powered by AI
The report of Walvax Biotechnology Co Ltd uses intelligence from across the web and also from available filings by Walvax Biotechnology Co Ltd. The assessment of Walvax Biotechnology Co Ltd is assembled by All Street Sevva using cutting edge Cognitive Robots. This dashboard contains a Q&A table for Walvax Biotechnology Co Ltd.
Walvax Biotechnology Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Walvax Biotechnology Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Walvax Biotechnology Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Walvax Biotechnology Co Ltd disclose current and historical energy intensity?
Does Walvax Biotechnology Co Ltd report the average age of the workforce?
Does Walvax Biotechnology Co Ltd reference operational or capital allocation in relation to climate change?
Does Walvax Biotechnology Co Ltd disclose its ethnicity pay gap?
Does Walvax Biotechnology Co Ltd disclose cybersecurity risks?
Does Walvax Biotechnology Co Ltd offer flexible work?
Does Walvax Biotechnology Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Walvax Biotechnology Co Ltd disclose the number of employees in R&D functions?
Does Walvax Biotechnology Co Ltd conduct supply chain audits?
Does Walvax Biotechnology Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Walvax Biotechnology Co Ltd conduct 360 degree staff reviews?
Does Walvax Biotechnology Co Ltd disclose the individual responsible for D&I?
Does Walvax Biotechnology Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Walvax Biotechnology Co Ltd disclose current and / or historical scope 2 emissions?
Does Walvax Biotechnology Co Ltd disclose water use targets?
Does Walvax Biotechnology Co Ltd have careers partnerships with academic institutions?
Did Walvax Biotechnology Co Ltd have a product recall in the last two years?
Does Walvax Biotechnology Co Ltd disclose incidents of discrimination?
Does Walvax Biotechnology Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Walvax Biotechnology Co Ltd issued a profit warning in the past 24 months?
Does Walvax Biotechnology Co Ltd disclose parental leave metrics?
Does Walvax Biotechnology Co Ltd disclose climate scenario or pathway analysis?
Does Walvax Biotechnology Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Walvax Biotechnology Co Ltd disclose the pay ratio of women to men?
Does Walvax Biotechnology Co Ltd support suppliers with sustainability related research and development?
Does Walvax Biotechnology Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Walvax Biotechnology Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Walvax Biotechnology Co Ltd involved in embryonic stem cell research?
Does Walvax Biotechnology Co Ltd disclose GHG and Air Emissions intensity?
Does Walvax Biotechnology Co Ltd disclose its waste policy?
Does Walvax Biotechnology Co Ltd report according to TCFD requirements?
Does Walvax Biotechnology Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Walvax Biotechnology Co Ltd disclose energy use targets?
Does Walvax Biotechnology Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Walvax Biotechnology Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Walvax Biotechnology Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.